282 related articles for article (PubMed ID: 22964633)
21. Nutlin-3 cooperates with doxorubicin to induce apoptosis of human hepatocellular carcinoma cells through p53 or p73 signaling pathways.
Zheng T; Wang J; Song X; Meng X; Pan S; Jiang H; Liu L
J Cancer Res Clin Oncol; 2010 Oct; 136(10):1597-604. PubMed ID: 20174822
[TBL] [Abstract][Full Text] [Related]
22. Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1.
Viejo-Borbolla A; Ottinger M; Brüning E; Bürger A; König R; Kati E; Sheldon JA; Schulz TF
J Virol; 2005 Nov; 79(21):13618-29. PubMed ID: 16227282
[TBL] [Abstract][Full Text] [Related]
23. A potential alpha-helix motif in the amino terminus of LANA encoded by Kaposi's sarcoma-associated herpesvirus is critical for nuclear accumulation of HIF-1alpha in normoxia.
Cai Q; Murakami M; Si H; Robertson ES
J Virol; 2007 Oct; 81(19):10413-23. PubMed ID: 17634230
[TBL] [Abstract][Full Text] [Related]
24. Kaposi Sarcoma Herpesvirus (KSHV) Latency-Associated Nuclear Antigen (LANA) recruits components of the MRN (Mre11-Rad50-NBS1) repair complex to modulate an innate immune signaling pathway and viral latency.
Mariggiò G; Koch S; Zhang G; Weidner-Glunde M; Rückert J; Kati S; Santag S; Schulz TF
PLoS Pathog; 2017 Apr; 13(4):e1006335. PubMed ID: 28430817
[TBL] [Abstract][Full Text] [Related]
25. Functional p53 signaling in Kaposi's sarcoma-associated herpesvirus lymphomas: implications for therapy.
Petre CE; Sin SH; Dittmer DP
J Virol; 2007 Feb; 81(4):1912-22. PubMed ID: 17121789
[TBL] [Abstract][Full Text] [Related]
26. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
[TBL] [Abstract][Full Text] [Related]
27. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-Associated B-lymphoma cells and contributes to their proliferation.
Lu J; Verma SC; Murakami M; Cai Q; Kumar P; Xiao B; Robertson ES
J Virol; 2009 Jul; 83(14):7129-41. PubMed ID: 19439469
[TBL] [Abstract][Full Text] [Related]
28. Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.
Renne R; Barry C; Dittmer D; Compitello N; Brown PO; Ganem D
J Virol; 2001 Jan; 75(1):458-68. PubMed ID: 11119614
[TBL] [Abstract][Full Text] [Related]
29. Kaposi's Sarcoma-Associated Herpesvirus LANA Modulates the Stability of the E3 Ubiquitin Ligase RLIM.
Tadmor H; Greenway M; Ahuja A; Orgil O; Liao G; Ambinder RF; Hayward SD; Shamay M
J Virol; 2020 Feb; 94(5):. PubMed ID: 31801865
[TBL] [Abstract][Full Text] [Related]
30. Kaposi's sarcoma-associated herpesvirus LANA-1 interacts with the short variant of BRD4 and releases cells from a BRD4- and BRD2/RING3-induced G1 cell cycle arrest.
Ottinger M; Christalla T; Nathan K; Brinkmann MM; Viejo-Borbolla A; Schulz TF
J Virol; 2006 Nov; 80(21):10772-86. PubMed ID: 16928766
[TBL] [Abstract][Full Text] [Related]
31. Bub1 in Complex with LANA Recruits PCNA To Regulate Kaposi's Sarcoma-Associated Herpesvirus Latent Replication and DNA Translesion Synthesis.
Sun Z; Jha HC; Robertson ES
J Virol; 2015 Oct; 89(20):10206-18. PubMed ID: 26223641
[TBL] [Abstract][Full Text] [Related]
32. Ets-1-dependent expression of vascular endothelial growth factor receptors is activated by latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus through interaction with Daxx.
Murakami Y; Yamagoe S; Noguchi K; Takebe Y; Takahashi N; Uehara Y; Fukazawa H
J Biol Chem; 2006 Sep; 281(38):28113-21. PubMed ID: 16861237
[TBL] [Abstract][Full Text] [Related]
33. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus modulates cellular gene expression and protects lymphoid cells from p16 INK4A-induced cell cycle arrest.
An FQ; Compitello N; Horwitz E; Sramkoski M; Knudsen ES; Renne R
J Biol Chem; 2005 Feb; 280(5):3862-74. PubMed ID: 15525642
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of KSHV-infected primary effusion lymphomas in NOD/SCID mice by gamma-secretase inhibitor.
Lan K; Murakami M; Bajaj B; Kaul R; He Z; Gan R; Feldman M; Robertson ES
Cancer Biol Ther; 2009 Nov; 8(22):2136-43. PubMed ID: 19783901
[TBL] [Abstract][Full Text] [Related]
35. KSHV Genome Replication and Maintenance in Latency.
Ueda K
Adv Exp Med Biol; 2018; 1045():299-320. PubMed ID: 29896673
[TBL] [Abstract][Full Text] [Related]
36. KSHV LANA acetylation-selective acidic domain reader sequence mediates virus persistence.
Juillard F; de Miranda MP; Li S; Franco A; Seixas AF; Liu B; Álvarez ÁL; Tan M; Szymula A; Kaye KM; Simas JP
Proc Natl Acad Sci U S A; 2020 Sep; 117(36):22443-22451. PubMed ID: 32820070
[TBL] [Abstract][Full Text] [Related]
37. Kaposi's sarcoma herpesvirus lytic replication compromises apoptotic response to p53 reactivation in virus-induced lymphomas.
Sarek G; Ma L; Enbäck J; Järviluoma A; Moreau P; Haas J; Gessain A; Koskinen PJ; Laakkonen P; Ojala PM
Oncogene; 2013 Feb; 32(9):1091-8. PubMed ID: 22469985
[TBL] [Abstract][Full Text] [Related]
38. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus recruits uracil DNA glycosylase 2 at the terminal repeats and is important for latent persistence of the virus.
Verma SC; Bajaj BG; Cai Q; Si H; Seelhammer T; Robertson ES
J Virol; 2006 Nov; 80(22):11178-90. PubMed ID: 16928741
[TBL] [Abstract][Full Text] [Related]
39. Netrin-1 induces apoptosis in human cervical tumor cells via the TAp73alpha tumor suppressor.
Roperch JP; El Ouadrani K; Hendrix A; Emami S; De Wever O; Melino G; Gespach C
Cancer Res; 2008 Oct; 68(20):8231-9. PubMed ID: 18922894
[TBL] [Abstract][Full Text] [Related]
40. P53 family: at the crossroads in cancer therapy.
Alsafadi S; Tourpin S; André F; Vassal G; Ahomadegbe JC
Curr Med Chem; 2009; 16(32):4328-44. PubMed ID: 19754415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
